Cargando…
Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is a pathology that affects 50% of men over 50 years of age and 90% of men develop BPH in their eighth decade of life. In 2018, more than 1 billion men will be affected by this disease worldwide. However, the progression of BPH is highly complex and has been debate...
Autores principales: | Da Silva, Marcello Henrique Araujo, De Souza, Diogo Benchimol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327899/ https://www.ncbi.nlm.nih.gov/pubmed/30662879 http://dx.doi.org/10.2147/RRU.S155609 |
Ejemplares similares
-
Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia
por: Ansari, Mohammad Abdul Jalil, et al.
Publicado: (2008) -
SUN-747 Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia
por: Liu, Teresa T, et al.
Publicado: (2020) -
Sex Steroid Hormones in Serum and Tissue of Benign and Malignant Breast Tumor Patients
por: Mady, Essam A., et al.
Publicado: (2000) -
The effect of steroid hormones on the growth pattern and RNA synthesis in human benign prostatic hyperplasia in organ culture.
por: Lasnitzki, I., et al.
Publicado: (1975) -
Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)